164 related articles for article (PubMed ID: 22528799)
1. Evaluation of brain tumors using dynamic 11C-methionine-PET.
Aki T; Nakayama N; Yonezawa S; Takenaka S; Miwa K; Asano Y; Shinoda J; Yano H; Iwama T
J Neurooncol; 2012 Aug; 109(1):115-22. PubMed ID: 22528799
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of time-activity curves obtained from dynamic
Nomura Y; Asano Y; Shinoda J; Yano H; Ikegame Y; Kawasaki T; Nakayama N; Maruyama T; Muragaki Y; Iwama T
J Neurooncol; 2018 Jul; 138(3):649-658. PubMed ID: 29564749
[TBL] [Abstract][Full Text] [Related]
3. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
4. Optimization of scan initiation timing after
Nakajima R; Abe K; Momose M; Fukushima K; Matsuo Y; Kimura K; Kondo C; Sakai S
Ann Nucl Med; 2017 Feb; 31(2):190-197. PubMed ID: 27885545
[TBL] [Abstract][Full Text] [Related]
5. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
Yamaguchi S; Terasaka S; Kobayashi H; Narita T; Hirata K; Shiga S; Usui R; Tanaka S; Kubota K; Murata J; Asaoka K
No Shinkei Geka; 2010 Jul; 38(7):621-8. PubMed ID: 20628188
[TBL] [Abstract][Full Text] [Related]
6. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
8. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.
Nuutinen J; Jyrkkiö S; Lehikoinen P; Lindholm P; Minn H
Radiother Oncol; 1999 Sep; 52(3):225-32. PubMed ID: 10580868
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of
He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
[TBL] [Abstract][Full Text] [Related]
12. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence.
Ceyssens S; Van Laere K; de Groot T; Goffin J; Bormans G; Mortelmans L
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1432-7. PubMed ID: 16908552
[TBL] [Abstract][Full Text] [Related]
13. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment.
Minamimoto R; Saginoya T; Kondo C; Tomura N; Ito K; Matsuo Y; Matsunaga S; Shuto T; Akabane A; Miyata Y; Sakai S; Kubota K
PLoS One; 2015; 10(7):e0132515. PubMed ID: 26167681
[TBL] [Abstract][Full Text] [Related]
16. Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors.
Schinkelshoek M; Lopci E; Clerici E; Alongi F; Mancosu P; Rodari M; Navarria P; van der Hiel B; Scorsetti M; Chiti A
Tumori; 2014; 100(6):636-44. PubMed ID: 25688497
[TBL] [Abstract][Full Text] [Related]
17. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
[TBL] [Abstract][Full Text] [Related]
18. Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Utriainen M; Metsähonkala L; Salmi TT; Utriainen T; Kalimo H; Pihko H; Mäkipernaa A; Harila-Saari A; Jyrkkiö S; Laine J; Någren K; Minn H
Cancer; 2002 Sep; 95(6):1376-86. PubMed ID: 12216107
[TBL] [Abstract][Full Text] [Related]
19. Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging.
Nishii R; Higashi T; Kagawa S; Arimoto M; Kishibe Y; Takahashi M; Yamada S; Saiki M; Arakawa Y; Yamauchi H; Okuyama C; Hojo M; Munemitsu T; Sawada M; Kobayashi M; Kawai K; Nagamachi S; Hirai T; Miyamoto S
Contrast Media Mol Imaging; 2018; 2018():1292746. PubMed ID: 30026674
[TBL] [Abstract][Full Text] [Related]
20. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
Hirata T; Kinoshita M; Tamari K; Seo Y; Suzuki O; Wakai N; Achiha T; Umehara T; Arita H; Kagawa N; Kanemura Y; Shimosegawa E; Hashimoto N; Hatazawa J; Kishima H; Teshima T; Ogawa K
J Neurosurg; 2019 Sep; 131(3):676-686. PubMed ID: 30239314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]